Vascular endothelin-1 |
ET-1 |
Key mediator of vascular tone (vasoconstrictor); displays mitogenic properties in cardiovascular system. Found upregulated in atherosclerosis. |
Vascular endothelin growth factor |
VEGF |
Stimulates vasculogenesis and angiogenesis (including after injury); chemotatic for leukocytes. Contributes to atherosclerotic plaque progression and destabilization. |
Matrix metalloproteinase-3 |
MMP3 |
Collagenase involved in connective tissue remodeling and activation of other MMPs, such as MMP-7 and -9. Genetic variants of MMP3 are associated with plaque rupture and myocardial infarction. |
Matrix metalloproteinase-7 |
MMP7 |
Degrades proteoglycans, fibronectin, elastin, and casein and is involved in tissue remodeling and wound repair. Found upregulated in atherosclerosis. |
Matrix metalloproteinase-9 |
MMP9 |
Gelatinase associated with tissue remodeling and mobilization of hematopoietic progenitor cells. Found upregulated in atherosclerosis and activity is associated with plaque destabilization/rupture. |
Tissue inhibitor of metalloproteinase-2 |
TIMP2 |
Tissue inhibitor of MMPs; found upregulated in atherosclerotic vessels. |
Heme-oxygenase-1 |
HO-1 |
Enzyme that catalyzes degradation of heme; inducible in response to oxidative stress and cytokine expression. |
Thiobarbituric acid reactive substances |
TBARS |
Formed as a byproduct of lipid peroxidation; indicator of oxidative stress. Found increased in atherosclerotic vessels. |